| Bioactivity | N-Formyl-Nle-Leu-Phe-Nle-Tyr-Lys TFA (For-Nle-Leu-Phe-Nle-Tyr-Lys-OH TFA) is a formyl peptide receptor (FPR) agonist[1]. | ||||||
| Name | N-Formyl-Nle-Leu-Phe-Nle-Tyr-Lys | ||||||
| CAS | 71901-21-8 | ||||||
| Sequence | N-Formyl-{NLE}-Leu-Phe-{NLE}-Tyr-Lys | ||||||
| Shortening | N-Formyl-{NLE}-LF-{NLE}-YK | ||||||
| Formula | C43H65N7O9 | ||||||
| Molar Mass | 824.02 | ||||||
| Appearance | Solid | ||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||
| Storage | Sealed storage, away from moisture
*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture) |
||||||
| Reference | [1]. Stenfeldt AL, et al. The non-steroidal anti-inflammatory drug piroxicam blocks ligand binding to the formyl peptidereceptor but not the formyl peptide receptor like 1. Biochem Pharmacol. 2007 Oct 1;74(7):1050-6. |